SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : sgp(schering plough)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad who wrote (108)11/27/2003 2:07:24 PM
From: Home-Run  Read Replies (1) of 117
 
Schering-Plough "strong buy," estimates reduced

Tuesday, November 25, 2003 2:07:07 PM ET
Raymond James

NEW YORK, November 25 (New Ratings) - Analyst Michael Krensavage of Raymond James maintains his "strong buy" rating on Schering-Plough Corp (SGP), while reducing his estimates for the company. The target price is set to $25.

In a research note published this morning, the analyst mentions that Schering-Plough recently issued bonds worth of $2.4 billion. This is expected to exert a downward pressure on the company's EPS in the medium term on account of the rising interest expenses, the analyst says. The valuation of Schering-Plough’s stock is attractive, given the company's long term revenue upside potential, Raymond James believes.

© 2003 New Ratings

newratings.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext